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Background: Current treatments for low back pain have small effects. A research priority is 
to identify patient characteristics associated with larger effects for specific interventions. 
Objective: The aim of this study was to identify simple clinical characteristics of patients 
with chronic low back pain who would benefit more from either motor control exercises or 
graded activity. 
Design: This study was a secondary analysis of the results of a randomized controlled trial. 
Methods: 172 patients with chronic low back pain were enrolled in the trial which was 
conducted in Australian physical therapy clinics. The treatment consisted of 12 initial 
exercise sessions over an 8-week period and booster sessions at 4 and 10 months following 
randomization. The putative effect modifiers (psychosocial features, physical activity level, 
walking tolerance and self-reported signs of clinical instability) were measured at baseline. 
Measures of pain and function (both measured on a 0-10 scale) were taken at baseline, 2, 6 
and 12 months by a blinded assessor. 
Results: Self-reported clinical instability was a statistically significant and clinically 
important modifier of treatment response for 12-month function (interaction: 2.72; 95% CI 
1.39 to 4.06). Participants with high scores on the clinical instability questionnaire (>9) did 
0.76 points better with motor control whereas people who had low scores (<9) did 1.93 points 
better with graded activity.  Most other effect modifiers investigated did not appear to be 
useful in identifying preferential response to exercise type. 
Limitations: The psychometric properties of the instability questionnaire have not been fully 
tested.  
Conclusion: A simple 15-item questionnaire of features considered indicative of clinical 
instability can identify patients who respond best to either motor control exercise or graded 
activity.  
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Trial Registration: The trial was prospectively registered with the Australian New Zealand 
Clinical Trials Registry (ACTRN12607000432415).  
 
  
 5 
Introduction 
Randomized controlled trials and systematic reviews evaluating the effectiveness of 
interventions for patients with chronic nonspecific low back pain typically demonstrate small 
treatment effects.1 2 It has been proposed that it may be possible to identify patients who are 
more likely to respond to a specific treatment (compared to no treatment or an alternative 
treatment), and for whom treatment effects are larger.3 4 Investigating subgroups of patients 
with low back pain with specific characteristics who respond best to different treatments has 
been identified as the number one research priority in this field.5 6 
 
Exercise therapy is endorsed in guidelines7 and systematic reviews2 as an effective treatment 
for chronic low back pain. However, while more effective than no intervention the effect size 
of exercise, like other back pain treatments, is small. A meta-regression study8 investigated 
various aspects of exercise programs and identified that individually designed programs, that 
included stretching or strengthening, and that included supervision had larger treatment 
effects. To illustrate this result the effect of exercise estimated from all 43 trials in the review 
was 3.4 (95%CI 2 to 4.7) points reduction in pain, measured on a 0-100 pain scale, however 
the authors estimate that the effect would rise to 18.1 points (95%CI 11.1 to 25.0) for 
programs including the most effective intervention characteristics. Although it is plausible 
that identification of characteristics of the patients who respond best to different types of 
exercise may further enhance the treatment effects this is yet to be investigated.  
 
Motor control exercises (sometimes called lumbar stabilisation exercises) and graded activity 
using the principles of cognitive behavioural therapy are two popular forms of exercise 
therapy for people with chronic low back pain, with evidence of effectiveness from 
randomized controlled trials9 10 and systematic reviews.11 12 Motor control exercise uses a 
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motor learning approach to optimise control of the spine and pelvis via rehabilitation of 
posture, movement, and the co-ordination of muscles involved in the control and movement 
of the spine.13 Therefore, this treatment is expected to work best in those who have impaired 
control and coordination of the spinal muscles, which has been proposed to include both 
reduced and excessive spinal stability.14 15 Graded activity uses a cognitive behavioural 
approach to increase activity tolerance by addressing pain-related fear, kinesiophobia and 
unhelpful beliefs/behaviour about back pain while at the same time correcting physical 
impairments such as endurance, muscle strength and balance.10 Theoretically, this treatment 
should work best in patients who are physically deconditioned and have unhelpful beliefs 
about their back pain. Given that both these exercise interventions are based on specific 
rationales, plausible treatment effect modifiers related to characteristics of the patient can be 
explored. If characteristics of patients who respond best to one of these exercise interventions 
compared to the other can be identified, then patient outcomes could be improved. 
 
The aim of this study was to identify simple clinical characteristics of patients who would 
benefit more from motor control exercises compared to graded activity, or vice versa, by 
evaluating potential treatment effect modifiers, identified a priori based on each treatment 
rationale. Guidelines16 17 on evaluation of treatment effect modification and clinical 
prediction rules were followed to ensure high methodological quality.  
 
METHODS 
Design overview 
The data for this study were drawn from a randomized clinical trial18 comparing motor 
control exercises to graded activity for patients with chronic non-specific low back pain. The 
trial was conducted in Sydney and Brisbane physiotherapy clinics with participants enrolled 
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to the trial in the period October 2007 to November 2009. The trial including effect 
modification analyses was prospectively registered (ACTRN12607000432415) and the trial 
protocol published.19 The trial received funding from Australia’s National Health and 
Medical Research Council. Ethical approval for the trial was granted by the University of 
Sydney Human Research Ethics Committee (approval 12-2006/9704), the University of 
Queensland Human Research Ethics Committee (2007001583) and the Royal Brisbane and 
Women’s Hospital ethics board (2007001583). All patients signed an informed consent form 
prior to their inclusion in the study. 
 
Setting and participants 
Patients with LBP of greater than 3 months’ duration were invited to participate if they met 
the following criteria: 
 Chronic non-specific low back pain (>3months duration) with or without leg pain. 
 Currently seeking care for low back pain. 
 Between 18 and 80 years of age. 
 English speaker. 
 Suitable for active exercises. (by use of the Physical Activity Readiness Questionnaire 
from the American College of Sports Medicine Guidelines)20 
 Expected to reside in the Sydney or Brisbane region for the study duration. 
 Had a score of moderate or greater on question 7 (How much bodily pain have you 
had during the past week?) or 8 (During the past week, how much did pain interfere 
with your normal work, including both work outside the home and housework?”) of 
the 36-Item Short-Form Health Survey (SF36).  
 
 
 8 
Exclusions were: 
 Known or suspected serious pathology. 
 Nerve root compromise (at least two signs of the same spinal nerve: sensation loss, 
reduce or absent reflexes or myotomal weakness). 
 Pregnancy. 
 Previous spinal surgery or scheduled for surgery during trial. 
 Contraindication to exercise program. 
 
Randomisation and interventions 
The randomization sequence with a 1:1 allocation ratio was computer-generated by an 
investigator not involved in recruitment or treatment allocation. Allocation codes were 
concealed in sequentially numbered, sealed, opaque envelopes by an investigator not 
involved in the study. The primary goal of the motor control exercise program was to enable 
the patient to regain control and coordination of the spine and pelvis using principles of 
motor learning.21 The intervention was based on assessment of the individual participant’s 
trunk coordination (including consideration of muscle activation, posture and movement) and 
treatment goals (set collaboratively with the therapist). The first stage of the intervention 
includes the implementation of a protocol designed to improve the activation of muscles 
identified to have poor control such as transversus abdominis, multifidus and pelvic floor,22 
and reduce the activity of any muscles identified to be overactive such as the obliquus 
externus abdominis. The second stage include the progression of the exercises towards more 
functional activities using static then dynamic tasks,23  
 
The primary goal of the graded activity program was to increase activity tolerance by 
performing individualised and submaximal exercises. The program was based on the 
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activities that each participant identified to be problematic. The activities in the program were 
progressed in a time-contingent manner (rather than a pain-contingent manner) from the 
baseline-assessed ability to a target goal set jointly by participant and therapist. Participants 
received daily quotas and were instructed to perform the agreed amount. Cognitive 
behavioural principles were used to address negative behaviours and pain-related anxiety.  
Both programs are comprehensively described in the original publication including a table 
delineating specific characteristics of each intervention.18  
 
 
Baseline predictors of response 
Baseline characteristics of each trial participant were collected by a researcher who was 
blinded to the participant’s treatment allocation. Seven baseline characteristics that would 
plausibly predict preferential response to graded activity compared to motor control were 
selected a priori and are presented in Table 1. The predicted direction of effect was also 
defined for each predictor.17 
 
The seven putative predictors were measures of walking tolerance, habitual physical activity, 
self-reported signs of clinical instability, self-efficacy, coping strategies, fear and anxiety of 
pain and psychosocial risk factors. We chose measures to evaluate the constructs based on 
ease of clinical application and ready availability. The predictors were pre-specified in a 
published trial protocol19 however some changes to the protocol were required. We replaced 
the Three Minute Step Test with the Shuttle Walk test based upon feasibility testing prior to 
starting the trial. The laboratory measures of trunk proprioception, trunk stiffness, trunk 
muscle response and deep muscle control were not included in this analysis as these complex 
neurophysiological measures cannot be performed in a typical clinic and therefore did not 
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align with the aim of this study to identify simple clinical characteristics of patients who 
would benefit more from motor control exercises or graded activity. The complex 
neurophysiological measures were only collected in a subset of patients (n=76) and will be 
used in a further study investigating mechanisms. The instruments used in the current study, 
and their interpretation, are summarised in Table 1.  
 
Our hypothesis was that graded activity would be superior to motor control exercise in 
participants with low walking tolerance, low habitual physical activity, low self-reported 
clinical instability, low self-efficacy, low coping, high fear/anxiety and high psychosocial 
risk, and that motor control exercise would be superior to graded activity in participants with 
high self-reported instability.  
 
 
Outcomes and follow-up 
Measures of pain and function were taken at baseline, 2, 6 and 12 months by a blinded 
assessor. Pain was measured as the average pain over the last week using a 0-10 scale (low 
scores indicate less pain) and function was measured using the 0-10 Patient Specific 
Functional Scale (PSFS) (high scores indicate greater function).21 We chose the PSFS as it is 
more responsive than other measures such as the Roland Morris Disability Questionaire.21 
 
Data Analysis 
We prespecified a threshold of 2 units (~1.0 standard deviation) for a clinically important 
interaction effect for both outcomes.19 The sample size of 172 participants was calculated a 
priori to detect an interaction effect size of 1.0 standard deviation and a treatment main effect 
of 0.5 standard deviation with an alpha level of 0.05 and power of 0.80 and allowing for 10% 
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loss to follow-up and 10% treatment non-adherence.19 An intention to treat method was used 
in all statistical analyses. 
 
We investigated baseline patient characteristics associated with greater effect of graded 
activity versus motor control for the primary trial outcomes of pain and function at 2 and 12 
months (ie separate models for each of these two follow-ups). We did not analyse response to 
treatment at 6 months follow-up to decrease the number of models and therefore, the chance 
of type I error. Outcomes at 2 and 12 months represent short- and long-term follow-ups. We 
began by investigating individual factors but also investigated combinations of factors. 
Treatment effect modification was evaluated using a group x predictor interaction term.17 The 
models were built using the linear mixed models commands within IBM SPSS Statistics 
Version 21(IBM Corp, Armonk, New York).  
 
Univariate testing  
As the goal was to identify clinical subgroups that could be simply identified, we 
dichotomised the predictors using a median split and then built separate models to predict 
pain and function outcomes at 2 months and 12 months for the 7 predictors. The models 
included terms for patient group, predictor, and group x predictor. We built separate models 
for 2 and 12 months outcomes. The 2 months models included baseline and 2 months follow-
ups and the 12 months model included baseline and 12 months follow-up. Predictors that 
provided a p-value <0.20 for the group x predictor term proceeded to the multivariate testing. 
A median split was used to dichotomise the predictors. We did not perform analyses to 
choose an ‘optimal’ cutoff point as this approach is strongly advised against.22  
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Multivariate modeling 
As we were also interested in building a clinical prediction rule we attempted to build a 
multivariate model. We used a backwards selection procedure to build the models. We 
entered all predictors from the univariate models with a p-value <0.20 into the first 
multivariate model and then in subsequent models removed one predictor at a time starting 
with the predictor with the highest p-value until only predictors with a p-value <0.05 
remained. 
 
RESULTS 
Participant flow through the study is shown in Figure 1 and the baseline characteristics of the 
participants are shown in Table 2.  
 
Univariate testing 
The results of the univariate testing are shown in Table 3. The Lumbar Spine Instability 
Questionnaire, Coping Strategies Questionnaire, Pain Anxiety Symptom Scale and Orebro 
were found to be statistically significant (p<0.05) treatment effect modifiers for function at 
12 months but not at 2 months. For example the effect of graded activity versus motor control 
was greater in participants with low instability (Lumbar Spine Instability Questionnaire); the 
point estimate and 95%CI for the interaction was 2.72 (1.39 to 4.06) units on the 0-10 
function scale. The other three significant interaction effects favoured graded activity over 
motor control in participants with (i) low coping (Coping Strategies Questionnaire), (ii) low 
fear (Pain Anxiety Symptom Scale) and (iii) low psychosocial risk (Orebro) but did not reach 
our pre-specified threshold for an interaction of 2 units. Additionally, two predictors (fear and 
psychosocial risk) did not influence outcomes in the hypothesised direction. The adjusted 
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treatment effects in subgroups positive and negative on each statistically significant treatment 
effect modifier are shown in Table 4. 
 
To illustrate the effect of self-reported signs of instability on treatment effect, Figure 2 shows 
outcomes in both treatment groups at baseline, 2 and 12 months follow-up for all participants 
and then in a separate panel with the groups stratified using the median Lumbar Spine 
Instability Questionnaire score of 9. Patients with a Lumbar Spine Instability score of 9 or 
greater (i.e. high instability), are described as ‘positive’, and those with Lumbar Spine 
Instability score <9, are described as ‘negative’ on the questionnaire. At 12 months patients 
who were positive on the Lumbar Spine Instability questionnaire did 0.76 points better with 
motor control than graded activity, while patient who were negative on the Lumbar Spine 
Instability questionnaire did 1.93 points better with graded activity than motor control. This 
means that on a scale from 0-10, where 0 is low function and 10 is high function, an 
individual that does not have instability and received graded activity is ~2 points more 
functional a year after inclusion in the study than those that did not have instability and 
received motor control. This is a large difference that has been reported to be clinically 
significant.23 
 
Multivariate modeling 
The Lumbar Spine Instability Questionnaire, Coping Strategies Questionnaire, Pain Anxiety 
Symptom Scale and Orebro yielded p-values <0.20 for predicting function at 12 months and 
the Coping Strategies Questionnaire, Pain Anxiety Symptom Scale and Orebro yielded p-
values <0.20 for predicting pain at 12 months. These became candidate variables for the 
multivariate analysis. None of the predictors achieved p-values <0.20 for short-term 
outcomes. 
 14 
 
We were unable to build a multivariate model for pain or function outcomes at 12 months. 
The final pain model included the Orebro, which did not achieve a p-value <0.05. The final 
function model included the Lumbar Spine Instability Questionnaire, which did achieve a p-
value <0.05.  
 
DISCUSSION 
Statement of principal findings 
We found that motor control exercise provided better function outcomes at 12 months than 
graded activity in patients with self-reported signs of clinical instability (LSI score < 9), but 
in those who scored low on the questionnaire of clinical instability (LSI score ≥9, the 
situation was reversed and graded activity provided better function outcomes. This finding is 
consistent with the theoretical rationale for motor control training. The treatment effect 
modification was statistically significant and larger than the threshold of 2 units for a 
clinically important interaction effect we pre-specified in the published trial protocol.19 
Measures of coping, fear/anxiety and psychosocial risk also moderated the effect of treatment 
on function at 12 months but did not reach our pre-specified threshold. There were no 
statistically significant interactions for pain at 2 and 12 months or for function at 2 months.  
 
Strengths and weaknesses of the study 
The strengths of the study are that we tested effect modification in a high quality trial and we 
followed a pre-specified protocol. We investigated a limited number of pre-specified 
predictors underpinned by theory. The analysis used appropriately constructed interaction 
terms and we blinded assessors of outcome to predictors and group allocation. One of the 
potential problems with evaluating treatment effect modification is a high type I error rate 
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associated with repeated testing. To minimise this effect we undertook a stepped approach. 
Nevertheless we acknowledge that we have taken a fairly exploratory approach and that any 
positive results will need replication in an independent data set. Our view is that the results of 
this study should be viewed cautiously and it would be premature to advocate clinical 
application at this stage. We would also caution that the lumbar instability questionnaire was 
developed from the results of a Delphi study of experienced clinicians aiming to identify 
features associated with instability. Self-administration of the questionnaire required 
adjustment of some features, e.g. the consensus feature “Reports feelings of giving way or 
back giving out” became Item 1: “I feel like my back is going to give way or give out on 
me”. We performed post hoc evaluation of the internal consistency and the influence of floor 
and ceiling effects for the Lumbar Spine Instability Questionnaire in our sample. Cronbach’s 
Alpha was calculated as a measure of internal consistency and interpreted according to the 
threshold provided by de Vet24 and the threshold proposed by McHorney and Tarlov25was 
used to determine the presence of floor or ceiling effects. Cronbach’s Alpha for the LSI was 
0.69 (95%CI 0.62 to 0.76), this falls marginally below the lower bound of the acceptable 
range proposed by de Vet24 of 0.7 to 0.9. The distribution of scores on the scale showed that 
neither floor nor ceiling effects are of concern. As only 1 participant (0.6%) reported the 
maximum score on the scale and no participants reported the minimum score, these fall well 
below the threshold of 15% of the sample at each end point.25. Future comprehensive 
evaluation of the psychometric properties and interpretation of the questionnaire is required.  
 
Strengths and weaknesses in relation to other studies  
Although numerous studies have attempted to identify subgroups of responders to a specific 
treatment for low back pain, almost all are poorly designed and no previous randomized trials 
have investigated subgroups of responders to different exercise approaches.26 Arguably the 
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best study investigating a subgroup of responders to a specific treatment for low back pain is 
the study of Childs and colleagues who developed a rule to identify patients with low back 
pain who respond best to spinal manipulation treatment.27 Although these authors expressed 
effect modification in a slightly different way to that used in our study, it is possible to obtain 
equivalent data from interpolation of the figures in the paper. Treatment effect modification 
was ~25 units on the 0-100 Oswestry low back pain disability questionnaire at 1 week which 
is similar in magnitude to the effect we observed on function.   
  
Meaning of the study: implications for clinicians and policymakers 
Although it is essential to use interaction terms to test treatment subgroups, the interaction 
term itself does not describe the treatment effect within the group but rather the difference 
between the treatment effect in those meeting the subgroup and those who do not. What we 
can determine is that people with a score greater than or equal to 9 on the Lumbar Spine 
Instability questionnaire (clinical instability) did 0.76 points (Figure 1) better with motor 
control whereas in people who had low scores for the Lumbar Spine Instability questionnaire 
(<9) did 1.93 points better with graded activity. At 12 months, the treatment effect in 
subgroup negative people (1.93; 95% CI 0.85 to 3.01) was clearly statistically and clinically 
significant implying graded activity was clearly superior to motor control in these patients. 
The treatment effect in subgroup positive patients was smaller and not statistically significant 
(-0.76; 95% CI -1.58 to 0.07). It is essential to note that this study was comparing 2 effective 
interventions.28-30 Therefore an additional benefit of 0.76 points, by selecting motor control 
over graded activity in these patients is considered clinically important by the authors, 
especially considering the interventions carry similar costs and potential harms. The CIs cross 
zero likely due to lack of power and larger trials are needed in the future to validate the 
finding that people who score positively on the LSI questionnaire have slightly better 
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outcomes with motor control compared to graded activity. Using the LSI score to contribute 
to decision making between graded activity and motor control appears to have little downside 
as both treatments are effective and carry few risks. However, as is always the case, it is 
important to consider other factor such as patient preference and clinician expertise while 
making treatment decisions and not rely solely on LSI score. This appears to be particularly 
the case in people with positive LSI scores where the benefits of choosing motor control over 
graded activity are relatively small. 
 
As the current trial did not have a no-treatment control group, it is not possible to determine 
the effect of either intervention compared to no treatment. However, the unadjusted mean 
(95%CI) improvement in function from baseline in people who received graded activity and 
had low scores on the Lumbar Spine Instability questionnaire was 3.7 (2.8 to 4.5) whereas the 
improvement was less than half this (1.8 (1.1 to 2.5)) in those who received graded activity 
and had high scores on the Lumbar Spine Instability questionnaire. In those who received 
motor control exercise the improvement was 2.4 (1.7 to 3.0) in those who scored high on the 
Lumbar Spine Instability questionnaire and 1.7 (0.7 to 2.7) in those who scored low on the 
Lumbar Spine Instability questionnaire. If the results of the current study can be replicated 
they are a major breakthrough and have important implications for management of chronic 
low back pain. The results suggest that by targeting the right patients (those with clinical 
instability or not) to these two common exercise approaches we may have a simple, relatively 
cheap method to increase the effectiveness of these treatments for chronic low back pain 
patients. Implementation of this approach would be very simple as both treatments are 
already widely used and the method to identify subgroups of responders to each approach is 
very simple.  
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Unanswered questions and future research  
An interesting finding from our study is that the interaction effect was not statistically 
significant for function at 2 months although the mean estimate (0.82) suggests that at this 
early time point the scores on the Lumbar Spine Instability questionnaire were already 
associated with response to exercise type. This suggests we were not powered to identify 
these smaller early effects. Larger trials in the future should provide adequate power to assess 
the importance of the Lumbar Spine Instability questionnaire score to early response to 
graded exercise or motor control exercise. However, in patients with chronic low back pain 
long-term outcomes are widely considered most important. We did not find a statistically 
significant interaction effect for the Lumbar Spine Instability questionnaire on pain outcomes 
at 12 months; however, the estimate of -0.96 (-2.59 to 0.67) again suggests we were not 
powered to find these smaller effects. We used a median split to dichotomise the LSI and 
suggest the same cut point (i.e. > 9) is used in future validation studies; however, exploration 
of different cut points may also be valuable.  The current trial only investigated people with 
chronic low back pain and it is not clear if the findings would generalise to those with acute 
low back pain. It is in people with chronic low back pain that exercise is more widely 
recommended, however, the findings of the current study indicate the possibility of better 
effects of exercise in acute or sub-acute low back pain if better matched to the patient’s 
presentation. Future research is required to investigate this.  
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Table 1.  Description of candidate baseline predictors 
 
Construct Measure Description Scale 
range 
Interpretation & 
hypothesized effect 
Median 
split for 
analysis 
Walking 
tolerance31 
Shuttle Walk 
Test (SWT) 
The SWT is a 
paced walking 
tolerance test.  
Tested for 
reliability,32 33 
validity32 33 and 
responsiveness.34 
Meters 
walked 
High scores indicate 
greater walking 
tolerance.  
Graded activity 
superior to motor 
control in 
participants with 
low walking 
tolerance 
<420  
Habitual 
Physical 
activity35 
International 
Physical 
Activity 
Questionnaire 
(IPAQ) 
The IPAQ is a 
self-report 
measure of 
habitual physical 
activity. 
Tested for 
validity and 
reliability.35 
Metabolic 
equivalent 
minutes of 
activity 
per week 
High scores indicate 
greater habitual 
physical activity 
Graded activity 
superior to motor 
control in 
participants with 
low habitual 
physical activity 
 
<1413 
Clinical 
Instability36 
Lumbar Spine 
Instability 
Questionnaire 
(LSIQ) 
This is a 15-item 
self-report 
measure of 
features 
considered by an 
expert panel to 
be associated 
with clinical 
instability  
Has not yet been 
formally tested. 
0 to 15 High scores indicate 
greater self-reported 
clinical instability 
Graded activity 
superior to motor 
control in 
participants with 
low clinical 
instability 
 
<9 
Self-
efficacy37 
Pain Self 
Efficacy 
Questionnaire 
(PSEQ) 
The PSEQ is a 
10-item scale to 
measure 
confidence to 
complete a task 
despite pain 
Tested for 
validity.38 39 
0 to 100 High scores indicate 
greater self-efficacy 
Graded activity 
superior to motor 
control in 
participants with 
low self-efficacy 
 
<41 
Coping 
Strategies40 
Coping 
Strategies 
Questionnaire 
(CSQ) 
The CSQ is a 6 
item measure of 
coping in 
chronic pain 
patients. 
Tested for 
validity.41 42 
0 to 36 High scores indicate 
greater coping 
Graded activity 
superior to motor 
control in 
participants with 
low coping 
 
<11 
Fear and Pain Anxiety The PASS-20 is 0 to 100 High scores indicate <43 
 24 
anxiety of 
pain43 
Symptom 
Scale (short 
form) 
a 20 item scale 
to measure fear 
and anxiety 
regarding pain 
Tested for 
validity.44 
greater pain-related 
anxiety 
Graded activity 
superior to motor 
control in 
participants with 
high fear/anxiety 
 
Psychosocial 
risk factors45 
Orebro Low 
Back Pain 
Screening 
Questionnaire 
(Orebro) 
 
The Orebro is a 
24-item scale to 
measure 
psychosocial risk 
factors for poor 
outcomes 
 Tested for 
reliability46 and 
validity.47 48 
11 to 192 High scores indicate 
greater psychosocial 
risk 
Graded activity 
superior to motor 
control in 
participants with 
high psychosocial 
risk 
 
<103 
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Table 2.  Baseline characteristics of participants.  
 
Characteristic Graded activity 
(n= 86) 
Motor control 
(n= 86) 
Age (years) 49.6 (16.3) 48.7 (13.7) 
Female gender (n) 45 (52.3) 57 (66.3) 
Low back pain duration 
(months)  
100.7 (109.2) 74.0 (94.8) 
Smoker (n) 14 (16.3) 16 (18.6) 
Taking analgesics (n) 57 (66.3) 52 (60.5) 
Previous episode of low back 
pain (n) 
57 (66.3) 54 (62.8) 
Coping Strategy (CSQ) 10.8 (7.6) 12.4 (7.5) 
Psychosocial risk factors 
(Orebro)  
103.4 (26.9) 102.8 (20.4) 
Fear and anxiety of pain 
(PASS total score) 
40.1 (21.8) 44.8 (21.0) 
Self-efficacy (PSEQ) 40.9 (13.5) 38.7 (12.3) 
Habitual Physical Activity 
(IPAQ) 
3,196 (6,634.9) 4,603.7 (8,012.4) 
Clinical Instability (Lumbar 
Spine Instability 
Questionnaire) 
9.0 (3.1) 9.0 (2.7) 
Pain intensity (NRS) 6.1 (2.1) 6.1 (1.9) 
Function (PSFS) 3.6 (1.6) 3.7 (1.6) 
Disability (RMDQ-24) 11.2 (5.3) 11.4 (4.8) 
Continuous data are mean (SD), categorical data are n (%) 
CSQ (Coping Strategies Questionnaire) - 0 (good coping strategy) to 36 (worst coping strategy). 
Orebro Low Back Pain Screening Questionnaire - 11 (low risk of pain becoming persistent) to 192 
(high risk of pain becoming persistent). 
PASS total score (Pain Anxiety Symptom Scale total score) - 0 (low anxiety) to 100 (high anxiety). 
PSEQ (Pain Self-Efficacy Questionnaire) - 0 (high fear avoidance) to 100 (no fear avoidance). 
IPAQ (International Physical Activity Questionnaire) - metabolic equivalents-minutes/week. 
Lumbar Spine Instability Questionnaire - 0 (no instability) to 15 (high instability). 
NRS (Pain Numeric Rating Scale) - 0 (no pain) to 10 (worst pain imaginable). 
PSFS (Patient-Specific Functional Scale) - 0 (unable to perform activity) to 10 (able to perform 
activity at pre-injury level). 
RMDQ-24 (24-item Roland Morris Disability Questionnaire) - 0 (no disability) to 24 (high 
disability). 
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Table 3. Results of univariate testing of the dichotomised predictor variables on function scores. 
 
 Predictor Group Predictor x group term 
Pain 2 months    
LSI -0.94 (-2.06 to 0.19) p = 0.102 0.03 (-0.95 to 1.01) p = 0.949 -0.18 (-1.72 to 1.36) p = 0.816 
CSQ -1.07 (-2.16 to 0.03) p = 0.057 0.06 (-1.00 to 1.11) p = 0.915 0.08 (-1.44 to 1.60) p = 0.919 
PASS -0.64 (-1.77 to 0.48) p = 0.259 0.44 (-0.60 to 1.48) p = 0.403 -0.58 (-2.11 to 0.95) p = 0.457 
Orebro 0.85 (-1.95 to 0.26) p = 0.132 0.41 (-0.60 to 1.43) p =0.421 -0.72 (-2.22 to 0.77) p = 0.341 
IPAQ -0.19 (-1.36 to 0.98) p = 0.744 -0.43 (-1.65 to 0.78) p = 0.480 1.05(-0.64 to 2.74) p = 0.222 
PSES 1.23 (0.16 to 2.30) p = 0.025 0.01 (-1.04 to 1.07) p = 0.981 0.36 (-1.12 to 1.85) p = 0.629 
SWT 0.50 (-0.67 to 1.68) p = 0.399 -0.22 (-1.37 to 0.94) p = 0.713 0.62 (-1.05 to 2.29) p = 0.466 
    
PSFS 2 
months 
   
LSI 0.28 (-0.70 to 1.26) p = 0.574 -0.61 (-1.49 to 0.26) p = 0.169 0.82 (-0.55 to 2.19) p = 0.241 
CSQ 0.43 (-0.56 to 1.41) p = 0.395 -0.48 (-1.43 to 0.46) p = 0.316 0.25 (-1.10 to 1.61) p = 0.712 
PASS 0.60 (-0.40 to 1.59) p = 0.237 -0.60 (-1.53 to 0.33) p = 0.206 0.34 (-1.03 to 1.70) p = 0.629 
Orebro 0.99 (0.03 to 1.96) p= 0.044 -0.40 (1.31 to 0.51) p = 0.389 0.05 (-1.29 to 1.39) p = 0.941 
IPAQ -0.35 (-1.36 to 0.66) p= 0.494 -0.07 (-1.1 to 0.973) p = 0.899 -0.24 (-1.70 to 1.22) p = 0.744 
PSES -0.92 (-1.89 to 0.05) p = 0.064 -0.45 (-1.40 to 0.51) p = 0.357 0.03 (-1.38 to 1.38) p = 0.969 
SWT -0.75 (-1.77 to 0.28) p = 0.153 -0.01 (-1.02 to 0.99) p = 0.983 -0.64 (-2.09 to 0.81) p= 0.385 
    
Pain 12 
months 
   
LSI -0.56 (-1.74 to 0.62) p = 0.351 0.32 (-0.73 to 1.37) p= 0.544 -0.96 (-2.59 to 0.67) p = 0.247 
CSQ -0.27 (-1.44 to 0.89) p = 0.644 0.73 (-0.40 to 1.87) p = 0.205 -1.31 (-2.92 to 0.31) p = 0.113 
PASS 0.11 (-1.07 to 1.28) p = 0.857 0.80 (-0.33 to 1.93) p = 0.163 -1.48 (-3.10 to 0.14) p = 0.074 
Orebro -0.99 (-2.11 to 0.14) p = 0.084 0.76 (-0.31 to 1.83) p = 0.163 -1.44 (-2.98 to 0.11) p = 0.068 
IPAQ -0.18 (-1.42 to 1.07) p = 0.778 -0.74 (-2.03 to 0.55) p = 0.259 0.89 (-0.91 to 2.68) p = 0.331 
PSES 0.19 (-1.00 to 1.38) p = 0.754 -0.29 (-1.47 to 0.89) p = 0.633 0.73 (-0.92 to 2.37) p = 0.385 
SWT 1.08 (-0.20 to 2.36) p = 0.099 0.32 (-0.92 to 1.56) p = 0.608 -0.24 (-2.07 to 1.59) p = 0.799 
    
PSFS 12 
months 
   
LSI -0.33 (-1.28 to 0.61) p =0.486 -0.79 (-1.63 to 0.06) p=0.068 2.72 (1.39 to 4.06) p < 0.001 
CSQ 0.07 (-0.9 to 1.04)) p = 0.889 -0.76 (-1.7 to 0.19) p = 0.118 1.81 (0.47 to 3.16) p = 0.008 
PASS 0.22 -0.75 to 1.20) p=0.651 -0.62 (-1.58 to 0.33) p =0.201 1.49 (0.13 to 2.85) p = 0.032 
Orebro 0.73 (-0.22 to 1.68) p = 0.130 -0.50 (-1.4 to 0.41) p=0.282 1.37 (0.05 to 2.69) p = 0.041 
IPAQ -0.66 (-1.75 to 0.43) p = 0.233 0.28 (-0.85 to 1.40) p = 0.627 0.22 (-1.36 to 1.80) p = 0.783 
PSES -0.73 (-1.73 to 0.27) p = 0.152 0.28 (-0.71 to 1.28) p =0.574 -0.38 (-1.78 to 1.02) p = 0.590 
SWT -0.22 (-1.32 to 0.87) p = 0.685 0.24 (-0.82 to 1.30) p = 0.656 -0.72 (-2.2 to 0.85) p = 0.367 
    
 
Values are non standardized point estimates, 95% CI and associated p-value for the effect of the 
predictor, the main effect of treatment group and the interaction between predictor and treatment 
group on function scores. The reference category for predictor term is a score greater than or equal 
to the median and for group term is the motor control group. Positive interaction terms for PSFS 
(function) outcomes, and negative interaction terms for pain outcomes, indicate better response to 
graded activity exercises in those with lower scores on the predictor variable  
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Table 4. Adjusted function (PSFS) treatment effects in subgroup positive and subgroup negative 
participants for the statistically significant predictors only. 
 
  
 12 months follow-up 
  
LSI negative (<9) 
1.93 (0.85 to 3.01) 
LSI positive (≥9) -0.76 (-1.58 to 0.07) 
CSQ negative (<11) 1.02 (0.03 to 2.01) 
CSQ positive (≥11) -0.74 (-1.68 to 0.19) 
PASS total negative (<43) 0.87 (-0.15 to 1.89) 
PASS total positive (≥43) -0.62 (-1.56 to 0.31) 
Orebro negative (<103) 0.87 (-0.12 to 1.86) 
Orebro positive (≥103) -0.49 (-1.39 to 0.41) 
 
Lumbar Spine Instability Questionnaire - 0 (no instability) to 15 (high instability). 
CSQ (Coping Strategies Questionnaire) - 0 (good coping strategy) to 36 (worst coping strategy). 
PASS total score (Pain Anxiety Symptom Scale total score) - 0 (low anxiety) to 100 (high anxiety). 
Orebro Low Back Pain Screening Questionnaire - 11 (low risk of pain becoming persistent) to 192 
(high risk of pain becoming persistent). 
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Figure 1: Study flow diagram
355 patients 
referred to the study 
Graded Activity = 86 
(Sydney =65, Brisbane=21) 
All received allocated intervention 
Randomisation 
n=172 
Motor Control = 86 
(Sydney = 68, Brisbane=18) 
All received allocated intervention 
79 declined to 
participate 
104 ineligible 
Care providers (n=8) 
Number of patients treated by each 
provider 
(median =3.5, IQR =5.5) 
Care providers (n= 10) 
Number of patients treated by each 
provider  
(median = 9, IQR = 5.5) 
Allocation 
Care 
providers  
Analyses Analysed 
N=86  
Analysed 
N=86  
82 followed up at 2 months (95.3%) 
 
Lost to follow-up (n=4; 2 withdrew from 
study, 2 unknown reason) 
 
 
 
76 followed up at 2 months (88.4%) 
 
Lost to follow-up (n=10; 6 withdrew from 
study, 3 lack of time, 1 unknown) 
 
 
81 followed up at 6 months (94.2%) 
 
Lost to follow-up (n=5; 2 withdrew from 
study, 2 lack of time, 1 unknown) 
unknown) 
 
 
80 followed up at 12 months (93.0%) 
 
Lost to follow-up (n=6; 2 withdrew from 
study, 1 lack of time, 3 unknown) 
 
 
74 followed up at 6 months (86.0%) 
 
Lost to follow-up (n=12; 7 withdrew from 
study, 3 uncontactable, 2 lack of time) 
 
 
75 followed up at 12 months 87.2%) 
 
Lost to follow-up (n=11; 7 withdrew from 
study, 4 uncontactable) 
 
2 months 
follow-up  
6 months 
follow-up  
12 months 
follow-up  
 
Mean 11.1 (SD 4.0) of planned 14 sessions 
attended 
 
 
 
Mean 11.1 (SD 4.0) of planned 14 sessions 
attended 
 
Treatment 
adherence  
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Fig 2. Function outcomes at baseline and 12 month follow-up to illustrate the main effect of treatment and treatment effect 
modification. Values represent unadjusted means and 95%CI. Panel A shows data for all participants, Panel B shows the outcome 
when the groups are stratified by median score on the Lumbar Spine Instability questionnaire.
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LSI Questionnaire 
 
 
Please identify if the following activities, positions, or descriptions are 
appropriate in describing your current low back condition. You may check as 
many of the indicators that you feel are appropriate. 
 
Please mark the YES if the following descriptions are appropriate in 
describing your current condition and NO if the description does not describe 
your current condition.  
 
 YES NO 
I feel like my back is going to “give way” or “give out” on me   
I feel the need to frequently pop my back to reduce the pain   
I have frequent times when my pain occurs throughout the day   
I have a past history where my back catches or locks when I twist 
or bend my spine 
 
 
I have pain when I sit to stand or stand to sit    
I have a lot of pain when I sit up from lying down if I don’t raise 
up the right way 
 
 
My pain is sometimes increased with quick, unexpected, or mild 
movements 
 
 
I have difficulty sitting without a back support like a chair and 
feel better with a supportive backrest 
 
 
I cannot tolerate prolonged positions when I can’t move   
It seems like my condition is getting worse over time   
I have had this problem a long time   
I sometimes get temporary relief with back brace or corset   
I have many occasions when I get muscle spasms   
I sometimes am fearful to move because of my pain   
I have had a back injury from trauma in the past   
 
